Yumanity Therapeutics Inc (YMTX) is lower by 4.02% Friday In Premarket Trading

Friday, December 16, 2022 07:02 AM | InvestorsObserver Analysts

Mentioned in this article

Yumanity Therapeutics Inc (YMTX) is lower by 4.02% Friday In Premarket Trading

Yumanity Therapeutics Inc (YMTX) is lower by Friday morning, with the stock decreasing -4.02% in pre-market trading to 1.67. YMTX's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 128 out of 146 industries, Yumanity Therapeutics Inc ranks higher than 4% of stocks. Yumanity Therapeutics Inc has fallen 4.40% over the past month, closing at $1.85 on November 18. During this period of time, the stock fell as low as $1.68 and as high as $2.22. YMTX has an average analyst recommendation of Strong Buy.

YMTX has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on YMTX!

See Full YMTX Report

Yumanity Therapeutics Inc has a Long-Term Technical rank of 71. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 29% of the market scoring higher. In the Biotechnology industry which is number 128 by this metric, YMTX ranks better than 128% of stocks.

Important Dates for Investors in YMTX:

-Yumanity Therapeutics Inc is set to release earnings on 2/12/2023. Over the last 12 months, the company has reported EPS of $-3.00. -We do not have a set dividend date for Yumanity Therapeutics Inc at this time. Click Here To Get The Full Report on Yumanity Therapeutics Inc (YMTX)